Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011
Naomi P.O'Grady, M.D., Mary Alexander, R.N.2, Lillian A.Burns, M.T., M.P.H., C.I.C.3, Patchen Dellinger, M.D.4, Jeffery Garland, M.D., S.M.5, Stephen O.Heard, M.D.6, Pamela A.Lipsett, M.D.7, Henry Masur, M.D.1, Leonard A.
Mermel, D.O., Sc.M.8, Michele L.
9, Issam I.Raad, M.D.10, Adrienne Randolph, M.D., M.Sc.11, Mark E.Rupp, 12, Sanjay Saint, M.D., M.P.H.and the Healthcare Infection Control Practices Advisory Committee (HICPAC).1National Institutes of Health, Bethesda, Maryland 2Infusion Nurses Society, Norwood, Massachusetts 3Greenich Hospital, Greenwich, Connecticut 4University of Washington, Seattle, Washington 5Wheaton Franciscan Healthcare-St.
Joseph, Milwaukee, Wisconsin 6 University of Massachusetts Medical School, Worcester, Massachusetts 7Johns Hopkins University School of Medicine, Baltimore, Maryland 8Warren Alpert Medical School of Brown University and Rhode Island Hospital,
Providence, Rhode Island 9Office of Infectious Diseases, CDC, Atlanta, Georgia 10MD Anderson Cancer Center, Houston, Texas 11The Children's Hospital, Boston, Massachusetts 12University of Nebraska Medical Center, Omaha, Nebraska 13Ann Arbor VA Medical Center and University of Michigan, Ann Arbor, MichiganGuidelines for the Prevention of Intravascular Catheter-Related Infections
14 Healthcare Infection Control Practices Advisory , Patrick J., MD Chief Medical Officer Division of Infectious Diseases University of Pennsylvania Health , Dale, DO, MPH President and CEO Oklahoma Foundation for Medical Quality
BURNS, Lillian A., MT, MPH Infection Control Coordinator Greenwich Hospital, Infectious Diseases Department
ELWARD, Alexis, MD Assistant Professor, Pediatrics Infectious Diseases Washington University School of Medicine Department of Pediatrics Division of Infectious Diseases
HUANG, Susan, MD, MPH Assistant Professor Medical Director, Epidemiology and Infection Prevention Division of Infectious Diseases UC Irvine School of Medicine
LUNDSTROM, Tammy, MD, JD Chief Medical Officer Providence Hospital
MCCARTER, Yvette S., PhD
Director, Clinical Microbiology
Laboratory Department of Pathology University of Florida Health , Denise M.RN, MPH, CIC Vice President, Quality and Patient Safety
Main Line Health System
EXECUTIVE SECRETARY BELL, Michael R., MD Deputy Director Division of Healthcare Quality Promotion Centers for Disease Control and Prevention OSTROFF, Stephen, MD Director, Bureau of Epidemiology Pennsylvania Department of Health
OLMSTED, Russell N., MPH, CIC Epidemiologist Infection Control Services St.Joseph Mercy Health System
PEGUES, David Alexander, MD Professor of Medicine, Hospital Epidemiologist David Geffen School of Medicine at UCLA
PRONOVOST, Peter J., MD, PhD, FCCM Director, Johns Hopkins Quality and Safety Research Group Johns Hopkins Quality and Safety Research Group
SOULE, Barbara M., RN, MPA, CIC Practice Leader Infection Prevention and Control Services Joint Commission Resources/Joint
SCHECTER, William, P., MD Professor of Surgery Department of Surgery San Francisco General Hospital
Guidelines for the Prevention of Intravascular Catheter-Related Infections
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S.Department of Health and Human Services.
EX-OFFICIO MEMBERS Agency for Healthcare Research and
BAINE, William B., MD Senior Medical Advisor Center for Outcomes and Evidence
Center for Medicare & Medicaid Services (CMS) MILLER, Jeannie, RN, MPH Deputy Director, Clinical Standards Group
Food and Drug Administration (FDA) MURPHEY, Sheila A
Division of Anesthesiology, General Hospital Infection Control Dental Devices Center for Devices and Radiology Health
LIAISONS Advisory Council for the Elimination of
Tuberculosis (ACET) STRICOF, Rachel L., MPH
American College of Occupational and Environmental Medicine RUSSI, Mark, MD, MPH Professor of Medicine Yale University School of Medicine Director, Occupational Health Yale-New Haven Hospital
American Health Care Assn (AHCA) FITZLER, Sandra L., RN Senior Director of Clinical Services
American Hospital Association (AHA) SCHULMAN, Roslyne, MHA, MBA Director, Policy Development
Association of Professionals of Infection
Control and Epidemiology, Inc.(APIC) DeBAUN, Barbara, MSN, RN, CIC
Association of periOperative Registered
Nursed (AORN) BLANCHARD, Joan C., RN, BSN
Council of State and Territorial Epidemiologists (CSTE) KAINER, Marion MD, MPH Director, Hospital Infections and Antimicrobial Resistance Program Tennessee Department Health National Institute of Health (NIH) HENDERSON, David, MD Deputy Director for Clinical Care Associate Director for Hospital Epidemiology and Quality Improvement NIH Clinical Center
Department of Veterans Affairs (VA) ROSELLE, Gary A., MD National Program Director, Infectious Diseases
VA Central Office Cincinnati VA Medical Center Consumers Union MCGIFFERT, Lisa
Senior Policy Analyst on Health Issues Project Director Stop Hospital Infections Organization
Infectious Disease Society of America (IDSA) HUSKINS, W.Charles MD, MSc Division of Pediatric Infectious Diseases
Assistant Professor of Pediatrics Mayo Clinic
Public Health Agency of Canada PATON, Shirley, RN, MN Senior Advisor Healthcare Acquired Infections
Center for Communicable Diseases and Infection Control
Society for Healthcare Epidemiology of America (SHEA) MARAGAKIS, Lisa, MD Assistant Professor of Medicine
John Hopkins Medical Institutions
Society of Hospital Medicine
SAINT, Sanjay, MD, MPH Director, Ann Arbor VA Me
Ntibiotic 1% w/w Chloramphenicol
Eye Ointment3.HOW TO USE YOUR MEDICINEChloramphenicol eye ointment is used by placing a small amount (about 1cm) in the space between the lower eyelid and the eye.
Always follow your pharmacists instructions.t%Pt%PBHFAdults and children aged 2 years and over:A course of treatment lasts 5 days:
tGsqueeze a thin line of ointment inside the lower eyelid of each affected eye 3 to 4 times a day.This means that you should use it about every 4 - 6 hours.tGduring the day and the eye ointment at night - apply the ointment at night, before going to bed.:PSsuitable treatment for , put about 1cm of ointment into the space between the lower eyelid t-FUblink a few times.This will help spread the t5Sanything else with the tip of the tube.t3FFBUt3FMBDFDBIt is important to complete the course of treatment even if your eyes feel better.Talk to your doctor immediately if: t:PSBUBOt5IFSFDo not repeat the course of treatment without consulting your doctor or pharmacist.If you miss a dose, use the ointment as directed above and then continue your normal course of treatment.Do not share your eye ointment with anyone If the contents of this tube are swallowed, contact your doctor straight away or go to your nearest hospital casualty department.
Take with you the tube and container so that the 4.POSSIBLE SIDE EFFECTSwithout any problems, but it can have side effects, like all medicines.
Side effects that may occur include:Reactions on or around the eye which are following side effects are very rare
including: tTFWFSFcalled aplastic anaemia), which may cause weakness or breathlessness.tMPFSmarrow depression) which may cause fever, joint pain or repeated infections.Grey baby syndrome in newborns and tMPtWPNUOHtCMFskin.If you have any of these symptoms, or have any other unusual symptoms or concerns with your medicine, stop using it and see your doctor or pharmacist straight away.5.STORING YOUR completing your 5 day course of treatment or return it to your pharmacist.Do not use the eye ointment if you notice any signs of deterioration.6.FURTHER 1% w/w Chloramphenicol Eye This medicine contains the active ingredient 1BSBGmOPPMBU:FMMPParafn.Each tube contains 4 grams of smooth yellow UIPSTBUPO5FYUSM.
Tags: antibiotic ointments for skin infections,best antibiotics for staph infections,antibiotic cream for skin infection,antibiotics used for skin infection,amoxicillin staph infection,best antibiotic for sinus infection,best antibiotic for skin infection,best antibiotic for ear infection,best antibiotic for tooth abscess